This Experimental Pill Could Become the First-Ever Drug for Cocaine Addiction
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month period than those on a placebo.
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month period than those on a placebo.
